TY  - GEN
AU  - Clark,J I
AU  - Kuzel,T M
AU  - Lestingi,T M
AU  - Fisher,S G
AU  - Sorokin,P
AU  - Martone,B
AU  - Viola,M
AU  - Sosman,J A
TI  - A multi-institutional phase II trial of a novel inpatient schedule of continuous interleukin-2 with interferon alpha-2b in advanced renal cell carcinoma: major durable responses in a less highly selected patient population
SN  - 0923-7534
PY  - 2002///1217
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - administration & dosage
KW  - Interleukin-2
KW  - Kidney Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Recombinant Proteins
KW  - Survival Analysis
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/annonc/mdf105
ER  -